Increased blood glucose levels following intra-articular injection of methylprednisolone acetate in patients with controlled diabetes and symptomatic osteoarthritis of the knee

Annals of the Rheumatic Diseases

Volumn 67, Issue 12, 2008, Pages 1790-1791

  Habib, G S ^a,b,c   Bashir, M ^b   Jabbour, A ^a  

^a Nazareth Hospital   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; METHYLPREDNISOLONE ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT;

DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; KNEE OSTEOARTHRITIS; LETTER; PHYSIOTHERAPY; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INJECTIONS, INTRA-ARTICULAR; MALE; METHYLPREDNISOLONE; OSTEOARTHRITIS, KNEE;

EID: 56749132908     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.089722     Document Type: Letter

References (4)

1. Panthakalam S, Phatnagar D, Klimiuk P. The prevalence and management of hyperglycemia in patients with rheumatoid arthritis on corticosteroid therapy. Scoff Med J 2004;49:139-41.
2. Uthman I, Raynauld JP, Haraoui B. Intra-articular therapy in osteoarthritis. Postgrad Med J 2003;79:449-53.
3. Armstrong RD, English J, Gibsn T, Chakraborty J, Marks V. Serum methylprednisolone levels following intraarticular injection of methylprednisolone acetate. Ann Rheum Dis 1981;40:571-4.
4. Bertouch JV, Sallustio BC, Mefflin BJ, Brooks BM. A comparison of plasma methylprednisolone concentrations following intra-articular injection in patients with rheumatoid arthritis and osteoarthritis. Aust N Z Med 1983;13:583-5.